Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Niels Mr van der Sangen

9PUBLICATIONS
21CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Medical biotechnology diagnostics (incl. biosensors)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

Sort by Publication Date:
|Feb 26, 2026
Genotype-Guided P2Y<sub>12</sub>-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.

W W A van den Broek, Jaouad Azzahhafi, Qiu Ying F van de Pol

|Nov 13, 2024
Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome.

Wout Willem Antoon van den Broek, Jaouad Azzahhafi, Dean R P P Chan Pin Yin

|Oct 29, 2024
Treatment Modifications in Acute Coronary Syndrome Patients Treated with Ticagrelor: Insights from the FORCE-ACS Registry.

Niels M R van der Sangen, Jaouad Azzahhafi, Dean R P P Chan Pin Yin

|Sep 08, 2023
One-year follow-up of patients treated with single antiplatelet therapy directly after percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.

Niels M R van der Sangen, Bimmer E P M Claessen, I Tarik Küçük

|Aug 01, 2023
Impact of recurrent ischaemic and bleeding events on quality of life in patients with acute coronary syndrome: Insights from the FORCE-ACS registry.

Niels M R van der Sangen, Jaouad Azzahhafi, Dean R P P Chan Pin Yin

|Aug 02, 2022
P2Y<sub>12</sub>-inhibitor monotherapy after coronary stenting: are all P2Y<sub>12</sub>-inhibitors equal?

Niels Mr van der Sangen, I Tarik Küçük, Jurriën M Ten Berg

Pageof 2

Frequent Collaborators

6 joint publications

José Ps Henriques

4 joint publications

Yolande Appelman

3 joint publications

Dean R P P Chan Pin Yin

3 joint publications

Melvyn Tjon Joe Gin

3 joint publications

Jurriën M Ten Berg

3 joint publications

Wouter J Kikkert

2 joint publications

Joyce Peper

2 joint publications

Georgios J Vlachojannis

2 joint publications

Rutger J van Bommel

2 joint publications

Bimmer Epm Claessen

Frequent Collaborators

6 joint publications

José Ps Henriques

4 joint publications

Yolande Appelman

3 joint publications

Dean R P P Chan Pin Yin

3 joint publications

Melvyn Tjon Joe Gin

Top Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on : Mar 15, 2022

6.0K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on : Jan 18, 2018

12.0K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on : Nov 08, 2024

793
See more related videos

Top Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on : Mar 15, 2022

6.0K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on : Jan 18, 2018

12.0K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on : Nov 08, 2024

793
See more related videos